211 related articles for article (PubMed ID: 35262978)
21. COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications.
Al Mahmasani L; Hodroj MH; Finianos A; Taher A
Ann Hematol; 2021 May; 100(5):1115-1122. PubMed ID: 33527161
[TBL] [Abstract][Full Text] [Related]
22. COVID-19 convalescent plasma donor characteristics, product disposition, and comparison with standard apheresis donors.
Lasky B; Goodhue Meyer E; Steele WR; Crowder LA; Young PP
Transfusion; 2021 May; 61(5):1471-1478. PubMed ID: 33458811
[TBL] [Abstract][Full Text] [Related]
23. Clinical use of Convalescent Plasma in the COVID-19 pandemic: a transfusion-focussed gap analysis with recommendations for future research priorities.
Al-Riyami AZ; Schäfer R; van den Berg K; Bloch EM; Estcourt LJ; Goel R; Hindawi S; Josephson CD; Land K; McQuilten ZK; Spitalnik SL; Wood EM; Devine DV; So-Osman C
Vox Sang; 2021 Jan; 116(1):88-98. PubMed ID: 32542847
[TBL] [Abstract][Full Text] [Related]
24. Rapid establishment of a COVID-19 convalescent plasma program in a regional health care delivery network.
Blackall D; Wulff S; Roettger T; Jacobs L; Lacasse A; Patri M; Zinser P; Pherez F; Jamkhana Z; Frey SE; Smith L; Goel R; Katz L
Transfusion; 2020 Oct; 60(10):2203-2209. PubMed ID: 32748963
[TBL] [Abstract][Full Text] [Related]
25. Effect of the COVID-19 pandemic on blood donations and transfusions in Nigeria - A multi-facility study of 34 tertiary hospitals.
Oreh A; Bozegha T; Ihimekpen A; Biyama F; Irechukwu C; Aliu S; Oshiame D; Nnabuihe A; Ndanitsa A; Nnachi O; Ogbenna A; Abubakar S; Olupitan F; Akinkunmi A; Ogunlade C; Abayomi T; Omokaro U; Sylvester C; Igiebor U; Wokoma B; Ebophni S; Adewuyi B; Dachi R; Muhammad H; Abubakar M; Mgbang J; Chineke A; Ogbuabor O; Fakai G; Hashim B; Adeluwoye N; Olanrewaju D; Agahiu E; Etim E; Alabi S; Akinbola I; Anibueze C; Awogbami O; Edowhorhu G; Adekoya-Benson T; Bello S; Ojuade Y; Amedu O
Niger J Clin Pract; 2022 Jun; 25(6):786-793. PubMed ID: 35708419
[TBL] [Abstract][Full Text] [Related]
26. Demographics of first-time donors returning for donation during the pandemic: COVID-19 convalescent plasma versus standard blood product donors.
Van Buren NL; Rajbhandary S; Reynolds V; Gorlin JB; Stramer SL; Notari EP; Conti G; Katz L; Stubbs JR; van Buskirk CM; Kuttner K; Smith DL; Ngamsuntikul SG; Pandey S; Ward DC; Ziman A; Hiskey M; Townsend M; Sachais BS
Transfusion; 2023 Mar; 63(3):552-563. PubMed ID: 36550639
[TBL] [Abstract][Full Text] [Related]
27. Provision of COVID-19 Convalescent Plasma in a Resource-Constrained State.
Ipe TS; Le T; Quinn B; Kellar S; Clark M; Carlisle S; Rassmann A; Hennigan S; Ridenour T; Roberts A; Avery D; Ryan S; Pearson S; Kothari A; Patil N
Transfusion; 2020 Dec; 60(12):2828-2833. PubMed ID: 32989778
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.
Li L; Yang R; Wang J; Lv Q; Ren M; Zhao L; Chen H; Xu H; Xie S; Xie J; Lin H; Li W; Fang P; Gong L; Wang L; Wu Y; Liu Z
Transfusion; 2020 Aug; 60(8):1773-1777. PubMed ID: 32491199
[TBL] [Abstract][Full Text] [Related]
29. Beyond COVID-19 and lessons learned in the United States.
Gammon R; Katz LM; Strauss D; Rowe K; Menitove J; Benjamin RJ; Goel R; Borge D; Reichenberg S; Smith R
Transfus Med; 2023 Feb; 33(1):6-15. PubMed ID: 35918741
[TBL] [Abstract][Full Text] [Related]
30. Hospital-Based Donor Recruitment and Predonation Serologic Testing for COVID-19 Convalescent Plasma.
Balcerek J; Trejo E; Levine K; Couey P; Kornberg ZV; Rogine C; Young C; Li PJ; Shy BR; Taylor JE; Bakhtary S; Friedlander T; Lynch KL; Bern C; Esensten JH
Am J Clin Pathol; 2021 Mar; 155(4):515-521. PubMed ID: 33399201
[TBL] [Abstract][Full Text] [Related]
31. Challenges in Establishing a Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Donation Program in a Multicultural Environment.
Algora M; Mehmood T; Madison DL; AlAmeri J; Abuzakouk M; Tagamtam M; Acena L; Totaan G; Grabski G; Oumeziane N; Rajani P; Taylor L; Guzman J; AbdelWareth LO
Arch Pathol Lab Med; 2021 Dec; 145(12):1479-1484. PubMed ID: 34407176
[TBL] [Abstract][Full Text] [Related]
32. Multi-institutional experience with COVID-19 convalescent plasma in children.
Jacquot C; Gordon O; Noland D; Donowitz JR; Levy E; Jain S; Willis Z; Rimland C; Loi M; Arrieta A; Annen K; Drapeau N; Osborne S; Ardura MI; Arora S; Zivick E; Delaney M
Transfusion; 2023 May; 63(5):918-924. PubMed ID: 36965173
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of coronavirus disease 19 convalescent plasma donors and donations in the New York metropolitan area.
Jain S; Garg K; Tran SM; Rask IL; Tarczon M; Nandi V; Kessler DA; Strauss D; Sachais BS; Yazdanbakhsh K; Rehmani S; Luchsinger L; Shi PA
Transfusion; 2021 Aug; 61(8):2374-2383. PubMed ID: 33904609
[TBL] [Abstract][Full Text] [Related]
34. Using automation to manage donor engagement and fine-tune supply and demand during the first year of the COVID-19 pandemic.
Pina T; Lewis M; Garrison C; Razatos A
Transfus Apher Sci; 2022 Aug; 61(4):103420. PubMed ID: 35277354
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of collecting and processing of COVID-19 convalescent plasma for treatment of COVID-19 in Uganda.
Muttamba W; Lusiba J; Namakula LO; Byakika-Kibwika P; Ssali F; Ddungu H; Mugenyi L; Kiwanuka N; Sekibira R; Kityo C; Keyune D; Acana S; Musinguzi A; Masasi A; Byamugisha J; Mpanju D; Musoki WJ; Tukamuhebwa HA; Nakwagala F; Bagaya BS; Kayongo A; Kimuli I; Nantanda R; Katagira W; Buregyeya E; Byanyima R; Byarugaba B; Siddharthan T; Mwebesa H; Charles O; Joloba ML; Bazeyo W; Kirenga B
PLoS One; 2021; 16(6):e0252306. PubMed ID: 34138909
[TBL] [Abstract][Full Text] [Related]
36. Impact of COVID-19 on blood centres in Zhejiang province China.
Wang Y; Han W; Pan L; Wang C; Liu Y; Hu W; Zhou H; Zheng X
Vox Sang; 2020 Aug; 115(6):502-506. PubMed ID: 32347566
[TBL] [Abstract][Full Text] [Related]
37. Managing blood supplies during natural disasters, humanitarian emergencies, and pandemics: lessons learned from COVID-19.
Van Denakker TA; Al-Riyami AZ; Feghali R; Gammon R; So-Osman C; Crowe EP; Goel R; Rai H; Tobian AAR; Bloch EM
Expert Rev Hematol; 2023; 16(7):501-514. PubMed ID: 37129864
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.
Yokoyama APH; Wendel S; Bonet-Bub C; Fachini RM; Dametto APF; Blumm F; Dutra VF; Candelaria GTP; Sakashita AM; Machado RRG; Fontão-Wendel R; Hamerschlak N; Achkar R; Assunção MSC; Scuracchio P; Nudelman V; Pastore L; Pinho JRR; Ben MD; Filho RK; Marra AR; Amano MT; Kallás EG; Helito AS; de Carvalho CRR; Araujo DB; Durigon EL; Camargo AA; Rizzo LV; Reis LFL; Kutner JM
Transfusion; 2021 Aug; 61(8):2295-2306. PubMed ID: 34173248
[TBL] [Abstract][Full Text] [Related]
39. Rapid development of a de novo convalescent plasma program in response to a global pandemic: A large southeastern U.S. blood center's experience.
Reik R; Gammon RR; Carol N; Smith J; Grable M; Forbes S; Wu Y; Reed L; Rogers M; Prichard A; Paul S; Scholl G
J Clin Apher; 2021 Aug; 36(4):533-546. PubMed ID: 33648025
[TBL] [Abstract][Full Text] [Related]
40. The impact of blood campaigns using mobile blood collection drives on blood supply management during the COVID-19 pandemic.
Halawani AJ
Transfus Apher Sci; 2022 Jun; 61(3):103354. PubMed ID: 35042671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
